Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-11-05, the close was $9.51: 3.1% below the 50-day average and 6.0% above the 200-day average, which is rising. RSI (14) is 51, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 66% of the way up its 52-week range of $6.75 to $10.94, on 1.8x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $9.82 | Price 3.1% below |
| 200-day average | $8.97 | Price 6.0% above, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 51 | Neutral range |
| MACD (12, 26, 9) | -0.05 vs -0.14 | Bullish cross in the last 10 days |
| 52-week range | $6.75 to $10.94 | 66% of the way up the range |
| Volume vs 20-day average | 1.8x | Heavy |
Base rates use NMR's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, NMR's 14-day RSI is 51, which is in the neutral range between 30 and 70.
Yes. NMR closed at $9.51 on 2026-11-05, 6.0% above its 200-day average of $8.97, which is rising. When it closed above its 200-day average (2,925 days), it was higher 63 trading days later 44% of the time, median -2.2%.
No. NMR closed at $9.51 on 2026-11-05, 3.1% below its 50-day average of $9.82. When it closed below its 50-day average (3,503 days), it was higher 63 trading days later 44% of the time, median -2.2%.
Yes, a bullish cross within the last 10 trading days. As of 2026-11-05 the MACD line is -0.05 against a signal line of -0.14, so MACD is bullish.
No. At $9.51 it sits 66% of the way up its 52-week range of $6.75 to $10.94, 13.1% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 1 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bullish, from the chart signal model.
NMR analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.